J. Jarabak

发表

Human placental 15-hydroxyprostaglandin dehydrogenase.

J. Jarabak, 1972, Proceedings of the National Academy of Sciences of the United States of America.

Isolation of two proteins with 9-ketoprostaglandin reductase and NADP-linked 15-hydroxyprostaglandin dehydrogenase activities and studies on their inhibition.

J. Jarabak, Y. M. Lin, 1978, Biochemical and biophysical research communications.

Polycyclic aromatic hydrocarbon quinones and glutathione thioethers as substrates and inhibitors of the human placental NADP-linked 15-hydroxyprostaglandin dehydrogenase.

R. Armstrong, R. Harvey, H. Chung, 1987, The Journal of biological chemistry.

Role of Quinone Metabolites in PAH Carcinogenesis

T. Penning, R. Harvey, J. Jarabak, 2000 .

Substrate specificity of three prostaglandin dehydrogenases.

D. Berkowitz, J. Jarabak, A. Luncsford, 1983, Prostaglandins.

Glutathione mixed disulfide inhibitors of the human placental NADP-linked 15-hydroxyprostaglandin dehydrogenase.

J. Fried, H. Chung, J. Jarabak, 1987, Prostaglandins.

Polycyclic aromatic hydrocarbon quinone-mediated oxidation reduction cycling catalyzed by a human placental NADPH-linked carbonyl reductase.

J. Jarabak, 1991, Archives of biochemistry and biophysics.

Improved safety of glucagon testing for pheochromocytoma by prior alpha-receptor blockade. A controlled trial in a patient with a mixed ganglioneuroma/pheochromocytoma.

W. Elliott, M. Murphy, J. Jarabak, 1989, Archives of internal medicine.

Studies on a 15-hydroxyprostaglandin dehydrogenase from human placenta. Purification and partial characterization.

S. Braithwaite, J. Jarabak, 1975, The Journal of biological chemistry.

Studies on the soluble 17 -hydroxysteroid dehydrogenase from human placenta. Evidence for a subunit structure.

J. Jarabak, M. A. Street, 1971, Biochemistry.

A souble 17 beta-hydroxysteroid dehydrogenase from human placenta. The binding of pyridine nucleotides and steroids.

J. Jarabak, G. Sack, 1969, Biochemistry.

Purification of the human placental NAD-linked 15-hydroxyprostaglandin dehydrogenase.

J. Watkins, J. Jarabak, 1988, Prostaglandins.

An NADP-linked prostacyclin dehydrogenase in rabbit kidney.

J. Jarabak, J. Korff, 1981, Prostaglandins.

Redox cycling of polycyclic aromatic hydrocarbon o-quinones: metal ion-catalyzed oxidation of catechols bypasses inhibition by superoxide dismutase.

R. Harvey, J. Jarabak, R. Jarabak, 1998, Chemico-biological interactions.

Redox cycling of polycyclic aromatic hydrocarbon o-quinones: reversal of superoxide dismutase inhibition by ascorbate.

R. Harvey, J. Jarabak, R. Jarabak, 1997, Archives of biochemistry and biophysics.

Biochemical studies of methotrexate resistance in choriocarcinoma of the human placenta and testis

N. Bachur, J. Jarabak, 1971 .

Inhibition of the human placental NAD- and NADP-linked 15-hydroxyprostaglandin dehydrogenases by nonsteroidal anti-inflammatory drugs.

J. Jarabak, 1988, Prostaglandins.

In vitro activity of nicotinamide adenine dinucleotide- and nicotinamide adenine dinucleotide phosphate-linked 15-hydroxyprostaglandin dehydrogenases in placentas from normotensive and preeclamptic/eclamptic pregnancies.

J. Watkins, M. Lindheimer, J. Jarabak, 1987, The Journal of clinical investigation.

Interactions between prostaglandin analogues and a receptor in bovine Corpora lutea. Correlation of dissociation constants with luteolytic potencies in hamsters.

B. Samuelsson, W. Powell, F. Sun, 1975, European journal of biochemistry.

[39] Soluble 17β-hydroxysteroid dehydrogenase of human placenta☆

J. Jarabak, 1969 .

Reversible cold inactivation of a 17β-hydroxysteroid dehydrogenase of human placenta: Protective effect of glycerol

P. Talalay, J. Jarabak, A. Seeds, 1966 .

Kinetic studies on a 15-hydroxyprostaglandin dehydrogenase from human placenta.

S. Braithwaite, J. Jarabak, 1976, Archives of biochemistry and biophysics.

Polycyclic aromatic hydrocarbon quinones may be either substrates for or irreversible inhibitors of the human placental NAD-linked 15-hydroxyprostaglandin dehydrogenase.

J. Jarabak, 1992, Archives of biochemistry and biophysics.

Isolation and properties of an NAD+-dependent 15-hydroxyprostaglandin dehydrogenase from human placenta.

J. Jarabak, 1982, Methods in enzymology.

Comparison of substrate specificities of the human placental NAD- and NADP-linked 15-hydroxyprostaglandin dehydrogenases.

J. Fried, J. Jarabak, 1979, Prostaglandins.

NADP-linked 15-hydroxyprostaglandin dehydrogenase from human placenta: partial purification and characterization of the enzyme and identification of an inhibitor in placental tissue.

J. Jarabak, Y. M. Lin, C. Westbrook, 1977, Biochemical and biophysical research communications.

Stereospecificity of hydrogen transfer by pyridine nucleotide-linked hydroxysteroid dehydrogenases.

P. Talalay, J. Jarabak, 1960, The Journal of biological chemistry.

15-ketoprostaglandin delta13 reductase from human placenta: purification, kinetics, and inhibitor binding.

J. Jarabak, C. Westbrook, 1978, Archives of Biochemistry and Biophysics.

The steroid specificity of the 17beta-hydroxysteroid dehydrogenase of human placenta.

J. Adams, P. Talalay, J. Jarabak, 1962, The Journal of biological chemistry.

A soluble dihydrofolate reductase from human placenta: purification and properties.

N. Bachur, J. Jarabak, 1971, Archives of biochemistry and biophysics.

Purification of a 17beta-hydroxysteroid dehydrogenase of human placenta and studies on its transhydrogenase function.

J. Adams, P. Talalay, H. G. Williams-Ashman, 1962, The Journal of biological chemistry.

[27] Isolation and properties of a 15-ketoprostaglandin Δ13-reductase from human placenta

J. Jarabak, 1982 .

Early steps in prostaglandin metabolism in the human placenta.

J. Jarabak, 1980, American journal of obstetrics and gynecology.

Purification and partial characterization of an NADH-linked delta13-15-ketoprostaglandin reductase from human placenta.

J. Jarabak, C. Westbrook, Carol A. Westbrook, 1975, Biochemical and biophysical research communications.

Partial isolation and characterization of the 15-hydroxyprostaglandin dehydrogenases and 9-ketoprostaglandin reductases in rabbit kidney.

J. Jarabak, J. Korff, 1980, Prostaglandins.

R. Heinrikson, J. Westley, J. Jarabak, 1981, Archives of biochemistry and biophysics.

Effect of ascorbate on the DT-diaphorase-mediated redox cycling of 2-methyl-1,4-naphthoquinone.

J. Jarabak, R. Jarabak, 1995, Archives of Biochemistry and Biophysics.

Studies on three reductases which have polycyclic aromatic hydrocarbon quinones as substrates.

R. Harvey, J. Jarabak, 1993, Archives of biochemistry and biophysics.

Irreversible inhibition of the human placental NADP-linked 15-hydroxyprostaglandin dehydrogenase/9-ketoprostaglandin reductase by glutathione thiosulfonate.

J. Fried, H. Chung, J. Jarabak, 1987, Prostaglandins.

The effect of NaCl intake on 9-ketoprostaglandin reductase activity in the rabbit kidney.

J. Watkins, J. Jarabak, 1985, Prostaglandins.

Oxidation of prostacyclin and its analogs by three 15-hydroxyprostaglandin dehydrogenases.

D. Berkowitz, F. Sun, J. Jarabak, 1984, Prostaglandins.

The inhibition of the soluble human placental 17-beta-hydroxysteroid dehydrogenase by o,p -DDD and its analogs.

J. Jarabak, M. A. Street, 1971, Endocrinology.

The purification and characterization of a prostacyclin dehydrogenase from rabbit kidney.

J. Jarabak, J. Korff, 1982, Journal of Biological Chemistry.

Gonadoblastoma and dysgerminoma in a true hermaphrodite with a 46,XX karyotype.

A. Talerman, A. Amarose, J. Jarabak, 1981, American journal of obstetrics and gynecology.

Metastatic adrenal cortical carcinoma. Prolonged regression with mitotane therapy.

K. Rice, J. Jarabak, J. Jarabák, 1981, JAMA.